SCHEMBL950500

SCHEMBL950500

C=CCSC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL458309 1.00
SCHEMBL19348074 0.79 TRPA1 (0.42)
SCHEMBL1457345 0.79 TRPA1 (0.42)
SCHEMBL467841 0.77
SCHEMBL9740049 0.76
SCHEMBL10817181 0.76 MITF (0.33)
SCHEMBL5807176 0.74
SCHEMBL1445277 0.74
SCHEMBL7313571 0.74
SCHEMBL28086 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011009059-A2 METHOD OF TREATING OR PREVENTING CANCER THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-01-20 WO claimed
WO-2011009059-A2 METHOD OF TREATING OR PREVENTING CANCER THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-01-20 WO disclosed
US-4680301-A 6-isothiocyanato-2,5-substituted benzothiazoles or benzoxazoles useful as anthelmintic effective agents CIBA-GEIGY CORPORATION (US) 1987-07-14 US disclosed